Compare UTG & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UTG | SHC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2003 | 2020 |
| Metric | UTG | SHC |
|---|---|---|
| Price | $40.83 | $15.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $20.33 |
| AVG Volume (30 Days) | 197.8K | ★ 3.7M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | N/A | $6.00 |
| P/E Ratio | ★ N/A | $170.39 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $33.50 | $10.80 |
| 52 Week High | $43.90 | $19.85 |
| Indicator | UTG | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 48.11 |
| Support Level | $38.52 | $15.18 |
| Resistance Level | $41.89 | $16.48 |
| Average True Range (ATR) | 0.84 | 0.45 |
| MACD | -0.32 | -0.06 |
| Stochastic Oscillator | 16.42 | 57.59 |
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.